Ardelyx (ARDX) Short term Debt (2018 - 2023)
Ardelyx posted quarterly Short term Debt of $27.1 million for Q2 2023, up 2.57% year-on-year from $26.4 million in Q2 2022, and up 0.64% on a QoQ basis from $26.9 million in Q1 2023.
Ardelyx (ARDX) has 6 years of Short term Debt data on file, last reported at $27.1 million in Q2 2023.
- For the quarter ending Q2 2023, Short term Debt rose 2.57% year-over-year to $27.1 million; the trailing twelve-month figure through Jun 2023 stood at $27.1 million (up 2.57% YoY), and the FY2022 full-year result was $26.7 million, down 17.21% from the prior year.
- Short term Debt for Q2 2023 stood at $27.1 million, up from $26.9 million in the prior quarter.
- Across five years, Short term Debt topped out at $44.4 million in Q3 2021 and bottomed at $1.2 million in Q4 2019.
- The 5-year median for Short term Debt is $26.5 million (2022), against an average of $22.5 million.
- The widest annual swing landed in 2021, when Short term Debt surged 674.27%; it then tumbled 40.28% in 2022.
- A 5-year view of Short term Debt shows it stood at $1.2 million in 2019, then jumped by 252.24% to $4.2 million in 2020, then soared by 674.27% to $32.3 million in 2021, then decreased by 17.21% to $26.7 million in 2022, then gained by 1.28% to $27.1 million in 2023.
- The last three Short term Debt figures came in at $27.1 million (Q2 2023), $26.9 million (Q1 2023), and $26.7 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 27.05 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 26.71 Mn |
| Sep 30, 2022 | 26.54 Mn |
| Jun 30, 2022 | 26.37 Mn |
| Mar 31, 2022 | 26.14 Mn |
| Dec 31, 2021 | 32.26 Mn |
| Sep 30, 2021 | 44.44 Mn |
| Jun 30, 2021 | 36.11 Mn |
| Mar 31, 2021 | 16.67 Mn |
| Dec 31, 2020 | 4.17 Mn |
| Jun 30, 2020 | 13.72 Mn |
| Mar 31, 2020 | 7.44 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Jun 30, 2018 | 546,000.00 |